ArticleClinical and experimental medicine2026
Single-cell spatial transcriptomics reveals clonal smooth muscle cell heterogeneity and programs associated with atherosclerotic plaque calcification.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cell-Surface Signatures and Targets of Modulated Vascular Smooth Muscle Cells in Atherosclerosis: From State Identification to Precision Intervention.Journal of cardiovascular development and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Osteochondrogenic transdifferentiation of vascular smooth muscle cells (SMCs) is a key driver of atherosclerotic calcification. Although SMC phenotypic plasticity has been well described, how clonally related SMCs interact with spatially defined microenvironments to drive calcification remains incompletely understood. We integrated single-cell RNA sequencing, mitochondrial mutation-based lineage tracing, and high-resolution spatial transcriptomics to construct a spatially resolved transcriptomic atlas of human carotid atherosclerotic plaques across AHA stages III-V. Plaque SMCs originated from multiple distinct clones, each capable of differentiating into diverse phenotypes. Pseudotime analysis revealed that fibroblast-like SMCs (FLSMCs), which arose from clones with higher mitochondrial mutation burdens, could transition into multiple SMC subtypes, including osteogenic-like SMCs (OLSMCs). In AHA stage IV-V plaques, OLSMCs were markedly enriched compared with stage III, particularly within peri-calcification zones located 0.16–0.32 mm from calcified regions. Within these niches, OLSMCs and foam macrophages (MPs) showed pronounced spatial enrichment (80–160 µm) and significant co-localization. Mechanistically, SPP1/FN1 signaling from foam MPs activated CD44/integrin pathways in OLSMCs, promoting calcification. These findings indicate that mitochondrial mutation-linked clonal expansion drives osteogenic differentiation within peri-calcification niches. Our data also suggest that the SPP1/FN1-CD44/integrin axis mediates inflammation-driven crosstalk between foam MPs and OLSMCs, providing a foundation for future studies of plaque calcification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.